MediPharm Labs receives cannabis drug license from Health Canada
February 17, 2021 By Grow Opportunity staff
Cannabis extraction company, MediPharm Labs, in Barrie, Ont. has received its Cannabis Drug License (CDL) from Health Canada.
This new license allows the company to manufacture and supply drugs that contain cannabis, including pharmaceutical prescription drugs that have been classified with a Drug Identification Number (DIN).
“This CDL licence enhances our opportunity and with our existing pharma customers, while also opening the door to working with additional large and smaller pharma companies, to produce existing approved cannabis drugs or develop and manufacture new and innovative drugs through later stage clinical trials,” said Keith Strachan, president and interim CEO of MediPharm Labs.
Print this page